Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749372 · ClinicalTrials.gov registry record · NA
MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00749372 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants.
The verdict
NCT00749372, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
A known risk of red blood cell transfusions is that it puts excess iron into the patient's body. Researchers are continually seeking the most effective method of measuring iron concentration. The purpose of this study is to determine how much iron has been deposited in a patient's heart and liver as a result of having received red blood cell transfusions using magnetic resonance imaging (MRI).
Interventions
- OTHER T2* Cardiac and Liver MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-07-31 |
| Est. Completion | 2013-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749372
The ClinicalTrials.gov registry entry for NCT00749372 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which T2* Cardiac and Liver MRI is the first listed.
NCT00749372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749372 about?
NCT00749372 is a clinical study titled "MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions". A known risk of red blood cell transfusions is that it puts excess iron into the patient's body. Researchers are continually seeking the most effective method of measuring iron concentration. The purpose of this study is to determine how much iron has been deposited in a patient's heart and liver as...
What is the current status of trial NCT00749372?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2008-07-31. Estimated completion is 2013-03-29.
What interventions are being tested in trial NCT00749372?
The interventions under investigation include: T2* Cardiac and Liver MRI (OTHER).
Who is sponsoring clinical trial NCT00749372?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.